Professor Noel Clarke

The Christie and Salford Royal Hospitals, Manchester UK

Noel Clarke is a Consultant Urological Surgeon at the Christie and Salford Royal Hospitals, Manchester and Honorary Professor of Urological Oncology at Manchester University. He specialises in secondary and tertiary referral complex pelvic and retroperitoneal surgery, research in to Genito-Urinary malignancy and the delivery of Cancer treatment in health care systems. He is closely involved with multiple large scale trials including the STAMPEDE trial which has changed international practice in prostate cancer serially in the last 5 years. He directs the Manchester University GU Ca Research Group and he leads the Manchester/Belfast FASTMAN Centre of Excellence for prostate cancer research. He is joint clinical lead for the National Prostate Cancer Audit in England and Wales. Professor Clarke’s research interests encompass basic/translational science and trials in urological cancer. He has authored multiple peer-reviewed papers and book chapters on urology and urological cancer.

dont miss

Improving Prostate Cancer Outcomes Through Cancer Trials

A resume of changes in treatment and improved outcomes in prostate cancer introduced as a consequence of randomised trials in the last 10 years


  • Lucinda Billingham: Speaking at the Oncology Convention

    Lucinda Billingham
    University of Birmingham - Cancer Research Clinical Trials Unit

    National Lung Matrix Trial: testing multiple novel targeted treatments

  • Dr Tony Dhillon: Speaking at the Oncology Convention

    Dr Tony Dhillon
    University of Surrey and Royal Surrey County Hospital

    Immunotherapy and Colon Cancer

  • Anders Johnsson: Speaking at the Oncology Convention

    Anders Johnsson
    Scandinavian ChemoTech AB

    Dynamic-ElectroEnhanced Chemotherapy brings relief to palliative patients with a large tumour burden

  • Professor David Snead: Speaking at the Oncology Convention

    Professor David Snead
    University Hospitals of Coventry and Warwickshire NHS Trust

    Digital Pathology – the scope and potential return on investment.

  • Dr. Konstantinos Vougas: Speaking at the Oncology Convention

    Dr. Konstantinos Vougas
    DeepMed IO Ltd

    AI in decision support of diagnostic and personalised medicine applications.